198 related articles for article (PubMed ID: 5030811)
1. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
2. Treatment of malignant melanoma with camptothecin (NSC-100880).
Gottlieb JA; Luce JK
Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
4. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
5. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
[No Abstract] [Full Text] [Related]
6. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
7. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
Weiss AJ; Wilson WL
Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
[No Abstract] [Full Text] [Related]
8. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).
Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB
Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015
[No Abstract] [Full Text] [Related]
9. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
10. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
[No Abstract] [Full Text] [Related]
11. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
Klaassen DJ; Rapp E
Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
[No Abstract] [Full Text] [Related]
12. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
[No Abstract] [Full Text] [Related]
13. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
[No Abstract] [Full Text] [Related]
14. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
15. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
Giles GR; Hall R; Brennan TG; Worthy TS
Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
[No Abstract] [Full Text] [Related]
16. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
Schubert JC; Martin H
Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
[No Abstract] [Full Text] [Related]
17. The variability of individual tolerance to methotrexate in cancer patients.
Hansen HH; Selawry OS; Holland JF; McCall CB
Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
[TBL] [Abstract][Full Text] [Related]
19. [A clinical study of N-nitrosomethylurea].
Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
[No Abstract] [Full Text] [Related]
20. Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
Falkson G; Falkson HC; du Plessis HE; Meyer TE
Cancer Clin Trials; 1980; 3(4):341-4. PubMed ID: 6159121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
